Life Table of Bactrocera zonata (Saunders) (Diptera: Tephritidae) for Sterile Insect Technique (SIT) in Mauritius

2021 ◽  
Vol 29 (2) ◽  
Author(s):  
R.D. Bhoyroo ◽  
S. Facknath ◽  
P. Sookar
2011 ◽  
Vol 38 (No. 2) ◽  
pp. 54-62 ◽  
Author(s):  
M.F. Mahmoud ◽  
M. Barta

Bactrocera zonata, a serious pest of fruits in many parts of the world, has recently been recorded in Northern Africa. Even though it has not been introduced to the European continent yet, a strong emphasis is being placed on developing effective measures to suppress this pest and to prevent it from establishing in neighbouring European countries. The sterile insect technique is widely used in integrated programmes against tephritid fruit flies and, in this paper, quality parameters of irradiated B. zonata were evaluated for possible use of sterile insect technique within the management of this pest. Pupae were irradiated (60Co) 48 h before adult emergence (in an air atmosphere) with doses of 10, 30, 50, 70 or 90 Gy. While adult emergence and egg hatch decreased with increasing dose, no significant differences in female fecundity were found among doses. Exposure of pupae to 90 Gy resulted in a total sterility of eggs laid by non-treated females crossed with treated males. Only insignificant difference in the radiation effect on female fecundity was found. Moderate effects on sex ratio and size were recorded, as they decreased gradually by increasing doses. No considerable effect on flying capability was observed, but generally, the percentage of fliers decreased with increasing radiation doses. Fried's competitiveness values of treated males (30 and 70 Gy) suggest that irradiated males compete successfully with non-irradiated ones.


1986 ◽  
Vol 56 (03) ◽  
pp. 268-270 ◽  
Author(s):  
M Morfini ◽  
D Rafanelli ◽  
G Longo ◽  
A Messori ◽  
P Rossi Ferrini

SummaryPost-infusion hepatitis is known to occur very frequently in haemophiliacs after treatment with unheated commercial clotting factor concentrates, obtained from large plasma donation pool. On the contrary, single-donor cryoprecipitate is likely to carry a lower risk of transmitting hepatitis.To evaluate this hypothesis, we retrospectively reviewed the medical records of 25 first infused haemophiliacs (from 1981 to 1984) treated with unheated commercial clotting factor concentrates (n = 19) or cryoprecipitate (n = 6).The hepatitis-free interval after the beginning of therapy was expressed as exposure days. The end point of each patient, i.e. the hepatitis occurrence, was defined as an increase of aminotransferases (ALT and AST) and/or the seroconversion of HBV-markers, which were checked every three months.The life-table method and log-rank test showed that cryo-precipitates had a significantly longer hepatitis-free interval (p = 0.0131, log-rank test) and a lower risk of transmitting hepatitis (p = 0.01-0.05, life-table method) than the commercial concentrates. However, the safety of cryoprecipitate therapy was shown to cover only a few exposure days, and so the real advantage of this product depends on the bleeding frequency of the patient concerned.We believe that these methods and our findings may be useful to assess and compare the safety of the new “heat-treated” clotting factor concentrates.


Sign in / Sign up

Export Citation Format

Share Document